Frontiers | Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
Frontiers | Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits,Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis | Journal of Medicinal Chemistry,Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer | Oncogene,Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients | Aging,Frontiers | Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node